EWM
Essex Woodlands Management Portfolio holdings
AUM
$279M
This Quarter Return
+18.82%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$564M
AUM Growth
+$564M
(+1.9%)
Cap. Flow
-$84.8M
Cap. Flow
% of AUM
-15.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$84.8M |
Sector Composition
| 1 | Healthcare | 97.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $160M | 28.32% | 946,818 -503,182 | -35% | -$84.8M |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $127M | 22.44% | 4,592,047 | – | – |
|
|
CORI
3
DELISTED
Corium International, Inc.
CORI
| $104M | 18.39% | 9,353,304 | – | – |
|
4
Axogen
AXGN
$743M
| $94.1M | 16.69% | 4,861,111 | – | – |
|
|
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $59.7M | 10.58% | 3,231,656 | – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $11.4M | 2.03% | 1,257,468 | – | – |
|
7
MediciNova
MNOV
$64.3M
| $7.46M | 1.32% | 1,170,370 | – | – |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $880K | 0.16% | 1,956,397 | – | – |
|
9
Gyre Therapeutics
GYRE
$703M
| $404K | 0.07% | 78,622 | – | – |
|